Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Macrogen
AddedFeb 20, 2024
UpdatedJun 28, 2026
Macrogen

Macrogen

Public

Macrogen Inc. offers DNA sequencing, genome research, and develops DNA chips for disease diagnosis and treatment.

HQ
Seoul, Seoul, KR
Founded
1997
Overview
Compare
Employees

Macrogen Inc., founded in 1997 by Jeong-sun Seo, is a global biotechnology company headquartered in Seoul, South Korea. The company specializes in DNA sequencing, genome research, and the development of DNA chips for disease diagnosis and treatment. Macrogen also provides bioinformatic analysis and supplies transgenic and knockout mice to biotechnology institutes and pharmaceutical companies.

Macrogen has achieved significant milestones, including its public listing on the Korea Exchange (KRX: 038290). The company operates globally through divisions in Korea, Japan, Oceania, Singapore, and Spain, and subsidiaries like Macrogen Europe BV and Psomagen Inc. Under the leadership of CEO Changhoon Kim, Macrogen continues to make impactful contributions to the fields of genomics and biotechnology.

Macrogen - Similar Companies

LabGenomics Co. logo

LabGenomics Co.

Lightspeed Genomics logo

Lightspeed Genomics

10x Genomics logo

10x Genomics

10xgenomics.com

Genome & Co logo

Genome & Co

Genome Insight logo

Genome Insight

Enzo Biochem logo

Enzo Biochem

Qiagen logo

Qiagen

qiagen.com

MacroGenics logo

MacroGenics

macrogenics.com

Sequegenics logo

Sequegenics

sequegenics.com

Sequencing.com logo

Sequencing.com

sequencing.com

Intact Genomics logo

Intact Genomics

intactgenomics.com

Mogene logo

Mogene

mogene.com

Epigentek Group logo

Epigentek Group

epigentek.com

Zymo Research logo

Zymo Research

zymoresearch.com

Phase Genomics logo

Phase Genomics

phasegenomics.com

Macrogen - Quick Facts

Who are Macrogen's competitors?

Companies similar to Macrogen include LabGenomics Co., Lightspeed Genomics, 10x Genomics and Genome & Co.

When was Macrogen founded?

Macrogen was founded in 1997.

Where is Macrogen's headquarters located?

Macrogen's headquarters is located in Seoul, Seoul, KR.

How many employees does Macrogen have?

Macrogen has 204 employees as of Feb 10, 2024.

Macrogen - Classification

Ownership
  • Public
Technology
  • Biotech
Model
  • Platform
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • DNA Sequencing
  • Genome Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 25 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 330000Manufacturing
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 7300Business Services
  • 8000Health Services
  • 5040Professional And Commercial Equipment And Supplies
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified